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Introduction
Hilar cholangiocarcinoma (HC), also known as ‘Klatskin tumor’, is a 
primitive adenocarcinoma of the proximal extra hepatic bile duct. It may 
involve either the common bile duct, the left or right main branches or the 
biliary confluence [1] and it is commonly classified on anatomical basis 
according to the modified Bismuth-Corlette classification [2]. It represents 
the most common type of cholangiocarcinoma with a prevalence of 46-
97% [3]. The prognosis has been strongly related to tumour resectability. 
Combined hepatic and biliary resection of the affected duct is an independent 
favourable survival prognostic factor [4]. Extended hepatic surgery is often 
required in order to achieve radical resection and survival benefit [5]. 
The most frequent clinical presentation is obstructive jaundice (80-
90%), alone or in association with itching, abdominal pain, cholangitis, 
malaise, malnutrition and renal failure. Elevated serum bilirubin at surgery 
is an independent risk factor for increased postoperative morbidity and 
mortality [6]; biliary drainage procedures aim to reduce bilirubin serum 
levels in obstructive jaundice. Although these techniques are affected by 
specific morbidity, it has been speculated that morbidity and mortality 
after major hepatectomy may be reduced if biliary drainage is performed 
preoperatively. The actual effectiveness of preoperative biliary drainage 
(PBD) has been widely debated in literature and a definitive consensus 
has to be reached yet. 
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Abstract
Background: To review the literature to investigate indications, advantages and complications of the different procedures for biliary drainage 
(percutaneous or endoscopic techniques) for resectable hilar cholangiocarcinoma. 
Methods: Pubmed and Medline databases were interrogated for articles published between January 1970 and November 2014. After 
screening for relevance, 56 articles were selected for the review.
Results: Hilar cholangiocarcinoma is the most common primitive adenocarcinoma of the bile ducts, involving the proximal extra hepatic 
biliary system. Prognosis has been strongly related to tumour’s resectability and extended combined hepatic and biliary resections are often 
required in order to achieve radical margin and survival benefit. Obstructive jaundice is the most common clinical presentation; preoperative 
hyperbilirubinemia is an independent risk factor for increased operative morbidity and mortality.
Conclusion: PBD was shown to be helpful only in those patients having a bilirubin level greater than 3-10 mg/dl; we might conclude that 
PBD is probably useless with bilirubin level below 3 mg/dl, advisable between 3-10 mg/dl and mandatory above 10 mg/dl especially in patients 
undergoing an extended hepatic resection.
In the initial management of HC, ENBD should be preferred as it is characterized by a less invasive approach and less complications (lower 
morbidity) . In case of suboptimal jaundice regression or in presence of complications PTBD might be combined, leaving EBD as last option. 
Drain should be limited to FLR. The optimal drain duration is debated: the drain should be left in place the time needed to reduce bilirubin level, 
meanly 2-6 weeks. 
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The aim of this review is to identify some principles that are currently 
recommended and commonly adopted in clinical practice.
Materials and Methods
We performed a systematic electronic review of English language 
published articles between January 1970 and November 2014 
using PubMed and Medline databases Search terms were: “Hilar 
Cholangiocarcinoma”, “Klatskin tumor”, “PBD” or “Preoperative biliary 
drainage”. All studies concerning hepatic resections in patients affected 
by HC were included in the study. Studies using PBD as simple palliation 
were excluded from the research. We mainly focused on articles which 
investigated how the presence or absence of preoperative biliary drainage 
(PBD) affects the surgical results. 
1484 studies were retrieved. 76 studies on hepatic resections for HC 
focusing on biliary drainage met the inclusion criteria; studies in which 
PBD was performed as palliative treatment were excluded. After screening 
for relevance, 56 articles were selected for the review.
Drainage techniques
An accurate analysis of the literature shows that the most frequently used 
techniques of BD are: endoscopic biliary drainage (EBD), percutaneous 
trans-hepatic biliary drainage (PTBD), and endoscopic nasobiliary 
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drainage (ENBD). To date, there are no prospective randomized controlled 
studies which compared the efficacy of those techniques as PBD of HC.
Endoscopic biliary drainage: EBD consists in an endoscopic drainage 
of bile duct by introducing a plastic or metallic stent. It is usually combined 
with sphincterotomy of the papilla of Vater. This technique has several 
advantages: it is more physiologic, it improves patient’s nutritional status, 
it reduces blood endotoxins, normalizes dyslipidemia and it improves 
immune response [7].
EBD in patients affected by tumors of proximal bile duct is often 
a difficult maneuver, affected by a high failure rate, which may require 
the association of more than one drainage techniques (usually PTBD). 
Moreover, after the procedure, evaluation of tumor length and extension 
may be less accurate in the presence of one or more stents and for local 
inflammation and fibrosis [8,9]. EBD is affected by an higher rate of post-
procedural complications compared to other techniques, with an overall 
25-50% morbidity and 3-5% mortality rate [9,10].
Percutaneous transhepatic biliary drainage: To date, PTBD is the 
most widely used technique for biliary drainage of proximal bile duct 
tumors. This technique consists of selectively cannulating the bile duct by 
a percutaneous approach, usually under ultrasound guide, and placement 
of one or more biliary stents in the biliary system. It has been reported that 
the post-procedural morbidity rate of percutaneous techniques is lower 
compared to the endoscopic technique [9]. PTBD is a direct approach for 
bile duct decompression in patient with HC and it is usually the procedure 
of choice in most groups due to effectiveness in decreasing serum bilirubin 
with low rates of cholangitis [9,10]. In particular, success rate of bile duct 
decompression is significantly higher by percutaneous approach than 
EBD in locally advanced HC [11]. 
Preoperative cholangiography made via PTBD may be helpful, 
in association with magnetic resonance cholangiopancreatography 
(MRCP), in determining tumor extension and preoperative staging 
according to Corlette-Bismuth classification. Nevertheless, PTBD is an 
invasive procedure which requires the insertion of one or more drainages 
through the hepatic parenchyma. One of the limits of this approach is 
the necessity of having dilated intrahepatic bile ducts prior the procedure, 
thus reducing the number of attempts needed to enter the bile duct. In 
absence of dilated bile duct, this technique may be long and laborious. 
The risk of vascular lesion and post-procedural haemorrhage does exist 
as reported by Kawakami [12], and tumor seeding of the drain tract has 
been histologically shown in the specimen with a rate of 5-20% [13,14]. 
Gerhards and co-authors suggested that preoperative radiotherapy of 
patients with resectable main bile duct tumor may reduce the risk of 
tumor seeding [14]. However, more recent studies reported a lower risk of 
seeding following PTBD compared to previous literature [15,16]. Further 
studies are needed in order to confirm these findings.
Endoscopic naso-biliary drainage: ENBD is a technique which 
consists in inserting a nasobiliary tube inside the dilated bile ducts via 
an endoscopic approach. A recent retrospective study compared the 
three principal techniques of biliary drainage, suggesting that naso-
biliary drainage of future liver remnant (FLR) may be the technique of 
choice for initial management of HC [12] due to reduced rate of post-
procedural complications compared to EBD and PTBD. Inflammatory 
response around bile ducts may be less severe with ENBD; as opposite 
to EBD, endoscopic sphincterotomy is frequently not required in relation 
to the small diameter of the nasobiliary tube compared with endoscopic 
stents whereas duodenal-biliary reflux is avoided with this approach [17]. 
Moreover, ENBD is preferred to PTBD due to the absence of tumour 
seeding of the drain tract associate with the percutaneous approach [12]. 
A Japanese retrospective study on 141 patients treated for HC in 
a single center from 2000 to 2008 [18] compared results of ENBD and 
PTBD with a mean follow up of 82 months. 121 out of 141 patients had 
severe obstructive jaundice (serum bilirubin >2.0 mg/dl) at presentation 
and were treated with PBD. Among the other 20 patients, 18 were drained 
with naso-biliary tube to prevent development of jaundice and PTBD was 
performed in the 2 remaining patients in order to obtain a preoperative 
cholangiography. ENBD was the initial technique of choice in most 
patients; one or two more drainage were inserted in the FLR in case of 
sub-optimal decompression or in the presence of cholangitis. PTBD was 
added to ENBD when the first procedure was ineffective or when a third 
nasobiliary tube was needed. The patients were divided in two groups 
for analysis: PTBD group (67 patients) and ENBD group (74). Overall 
survival rate was higher in the ENBD group compared to PTBD group 
(p 0.004). Multivariate analysis showed that preoperative PTBD was an 
independent predictor of poor survival compared to ENBD (HR 2.075, 
95% CI 1.279–3.709, p 0.003). In the percutaneous group, tumor seeding 
was detected in 3 patients (4.5% - one in the hepatic parenchyma and two 
in the extra-hepatic tract of the drainage). 
ENBD technique is not feasible in case of complete stenosis of 
the main bile duct; therefore its efficacy is limited in the majority of 
Corlette-Bismuth type IV HC [19]. Major drawbacks for ENBD are 
patient’s discomfort and high risk of displacement of the tube. Moreover, 
the reduction in serum bilirubin is reportedly lower than the other 
procedures and a longer preoperative hospital stay may be required; also, 
contemporary drainage of both liver lobes is not achievable with only one 
tube [20]. Interestingly, Yoshida et al suggested that per-os reintroduction 
of drained bile may improve immune and hepatic function and overall 
general status, supporting the hypothesis that bile replacement may be 
beneficial for patients undergoing major hepatectomy [21].
Discussion
Obstructive jaundice is the most common clinical presentation of 
primary bile duct malignancies; hyperbilirubinemia, with reported mean 
values of 15 mg/dl in serum bilirubin, is directly related to the site and 
extension of lesions in the common bile duct and to the degree of stenosis. 
High bilirubin level has been clearly shown to be a risk factor of increased 
morbidity and mortality in patients undergoing surgical operations for 
malignancies or benign diseases [22-25]. Extended hepatectomy in case 
of bile obstruction and jaundice may be associated with an increased 
postoperative morbidity and mortality [26-28].
Use of PBD for the reduction of serum bilirubin and associated 
operative risks is controversial. Some authors suggest that presence of 
PBD may increase infection rate of the biliary system thus increasing the 
risk of postoperative infectious complications [29,30]. In 2009, Kloek et 
al. [9] demonstrated an altered coagulation profile and an inflammatory 
status in case of severe hyperbilirubinemia. Moreover, it has been shown 
that obstructive jaundice may be associated with renal and hepatic 
insufficiency [22-24,31-34]. Other studies showed that severe jaundice 
and related complications (renal and hepatic insufficiency, malnutrition, 
sepsis) might be potentially reversible by correcting hyperbilirubinemia 
[35,36].
In the event of severe complications related to obstructive jaundice, the 
majority of authors recommend urgent treatment of hyperbilirubinemia, 
regardless of the origin of the disease; conversely, isolated finding of 
elevated serum bilirubin may not be per se an indication to perform PBD 
particularly in the case of malignancies involving the distal portion of 
common bile duct [20,37,38]. However, as far as HC is concerned, poor 
evidence is available and data appear discordant.
Preoperative Bilirubin level
A preoperative bilirubin level lower than 3 mg/dl has been 
recommended by Makuuchi et al. [39] and Nimura et al [40], thus 
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suggesting an important role of PBD in managing HC. A recent single 
center retrospective study [41] reviewed a 10 years’ experience of 105 
patients treated for HC. Mean bilirubin levels at diagnosis and at surgery 
were 5.9 mg/dl (range 0.5-34.6 mg/dl) and 1.6 mg/dl (0.3-21.8 mg/dl) 
respectively. 84 patients of 105, those with bilirubin level greater than 2 
mg/dl, were treated by PBD. After the procedure 72/84 (68.6% of total) 
had lowered their bilirubin level to less than 3 mg/dl before surgery. PTBD 
was the most frequently used approach. Thirty-nine patients (37.1%) were 
also treated for cholangitis. Persistence of cholangitis in the preoperative 
setting was found to be an independent predictor of mortality in 
univariate and multivariate statistical analysis. In multivariate analysis, a 
preoperative level greater than 3 mg/dl was found to be an independent 
prognostic factor of poor OS. 
Grandadam et al. [42] showed that hepatic optimization of liver function 
in HC reduces postoperative morbidity; in their cohort of patients, mean 
preoperative bilirubin level was 4.4 mg/dl. A retrospective study by 
Nakayama et al. demonstrated a reduction in postoperative mortality 
from 28.3% to 8.2% in patients with malignancies undergoing curative 
or palliative surgery when preoperative serum bilirubin was lower than 5 
mg/dl whereas mortality increased with bilirubin of 10 mg/dl or higher. 
The role of PBD in reducing postoperative mortality was evidenced in 
relation to decreasing preoperative bilirubin [22]. Findings by Denning 
et al. supported the hypothesis that postoperative morbidity and mortality 
rates are directly related to severity of preoperative hyperbilirubinemia 
[43]; also, considering preoperative bilirubin as the only predictor of 
postoperative morbidity and mortality in their analysis, no complications 
were reported among the 11 patients with values lower than 6 mg/dl. 
Some authors describe the risk factors to look at in the decisional 
work up of HC, such as bilirubin lower than 10 mg/dl [44,45]. Su et al. 
[26] showed relationship between post-operative mortality and bilirubin 
level >10 mg/dl. On the other side, in a single center retrospective study 
made in 2009 Figure as et al., [46] reviewed data of 19 patients treated for 
HC during a 3 years period (2005-2008), suggesting PBD only for those 
patients with bilirubin level greater than 15 mg/dl or with preoperative 
cholangitis, severe malnutrition or hypoalbuminemia (<3 mg/dl).
Optimal drain duration
Reduction of hyperbilirubinemia usually occurs in 14 days [47,48]. 
This period must be used to control nutritional level, to correct an altered 
coagulation status, blood count, renal insufficiency and eventually to 
eradicate bile infection from multi-drug resistant bacteria.
In the cohort by Denning et al, external biliary drainage was left in situ 
up to 72 days in order to achieve optimal in-hospital and outpatient care; 
complications developed in 10% of procedures and drain replacement 
was necessary in 5 patients [43]. In other series, PBD was maintained 
up to 1 year postoperatively without major complications. [22,49]. Even 
if experimental data suggest that complete recovery of hepatic function 
occurs in 6 weeks [50], a 2 to 3 weeks period of biliary drainage is 
currently applied in clinical practice [51-53]. In case of cholangitis or 
long lasting drain, PBD tube should be periodically replaced. In order 
to achieve a rapid bilirubinemia reduction, some authors supports the 
use of PTBD as a standard technique for patients undergoing hepatic 
resection for HC [40,54].
To drain or not to drain
Laurent work [55] shows that there is no difference in terms of post-
operative mortality and hepatic insufficiency after hepatic resection 
between patients with or without jaundice. Despite this conclusion, 
postoperative morbidity and pre-operative transfusion rate were higher 
in patients with obstructive jaundice. The most remarkable post-operative 
complications were bile leaks and subphrenic abscess, which occur more 
frequently in patients having pre-operative jaundice, increasing the 
number of days of hospitalization. Overall morbidity rate in icteric and 
non-icteric group were 50 and 15%, respectively. 
The authors do not recommend routinary use of PBD in HC. However, 
there might be some cases where it is still advised: these are patients 
with a FRL less than 40%, patients with cholangitis, long-time lasting 
jaundice, malnutrition or severe hypoalbuminemia. If we decide to use 
PBD, FLR should be drained and surgery should be performed with a 
bilirubin level of less than twice the normal range. In case of cholangitis 
or long lasting drain, PBD tube should be periodically replaced. When 
FLR doesn’t allow a safe resection, preoperative portal vein embolization 
(PVE) should be performed in order to achieve FLR hypertrophy, and in 
these cases preoperative PBD is usually necessary. PBD may be avoided 
in the following situations: short-time onset of jaundice (<2-3 weeks), 
total bilirubin level < 200 mmol/l, absence of sepsis, future liver remnant 
>40%. These criteria include most patients requiring left hepatic resection 
and selected patients needing right hepatectomy. In other cases, PBD is 
required, alone or in association with PVE in case of small FLR [55].
In a retrospective study on 71 patients treated for HC, Hochwald et al. 
[29] reported an increased risk of biliary infections (69%, p 0.001) and 
overall infectious complications (66%, p 0.03) in the drained group (42 
patients) compared to the non-drained group (29); bile contamination 
was found in 100% and 69% of patients drained with endoscopic or 
percutaneous approach respectively. Conversely, there were no significant 
differences in terms of postoperative non-infectious complications, 
hospital stay and rate of reoperations. It has to be noted that postoperative 
mortality was lower (although not statistically significant) in drained 
compared to non-drained patients, with a rate of 5% versus 14% 
respectively. 
Ferrero et al. [56] retrospectively reviewed outcomes of 30 combined 
hepatic and biliary resection for malignancies (mostly HC) over a 17 years 
period. Overall mortality, morbidity and major complications rate were 
not significantly different between drained and non-drained group (3% 
vs. 10%, p 0.612; 70% vs. 63%, p 0.583; 37% vs. 53%, p 0.194 respectively); 
notably, mortality rate of non-drained group was in fact three times 
higher than drained group. Patients with PBD showed a significant higher 
risk of infections (40% vs. 17%, p 0.044) whereas no significant difference 
was found between the two groups in non-infectious complications and 
hospital stay. PBD was the only independent risk factor associated with 
postoperative infectious complications (RR 4.411, 95% CI 1.216-16.002, 
p 0.024). 
Figueras et al. [46] reviewed a single center experience in treating 19 
patients for HC over a 3 years period (2005-2008): preoperative PBD was 
indicated in those patients having a preoperative level greater than 15 mg/
dl, if presenting with cholangitis or severe preoperative malnutrition or 
hypoalbuminemia (<3 mg/dl). Bile duct drainage was necessary in 7 cases 
(37%) and no significant differences were found between the two groups.
In a series of 38 patients operated for type III HC by the group in Rennes 
[42], preoperative liver optimization was achieved in 15 patients (12 
received drainage), reducing intra-abdominal abscess rate; no difference 
was found in terms of overall morbidity and survival. However, 4 non-
drained patients (among which 3 developed an abscess) accounted for the 
10.5% mortality. At multivariate analysis, preoperative jaundice was found 
to be associated with poor outcome.
Interestingly, a recent multicentric retrospective French study [57] 
suggested that PBD may be beneficial in particular for patients undergoing 
right hepatectomy (OR 0.29, 95% CI 0.11-0.77, p 0.013) because of higher 
mortality rate related to liver failure for this procedure. Conversely, 
drainage might increase mortality due to infectious complications in left 
hepatectomy for HC (OR 4.06, 95% CI 1.01-16.30, p 0.035).
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According to our review of literature, a definitive recommendation for 
routinary use of PBD in HC is not supported by the current evidence; 
however, drainage of the biliary system may be indicated in specific 
conditions: long-lasting jaundice with significant hyperbilirubinemia, 
cholangitis, malnutrition and severe hypoalbuminemia. PBD might 
be avoided in recently developed jaundice (less than 2-3 weeks), serum 
bilirubin < 200 mmol/l, absence of sepsis; these criteria include most 
patients requiring left hepatic resection and selected patients needing 
right hepatectomy [55]. Ratti et al. [8] showed that percutaneous biliary 
drainage placement is mandatory in candidates for PVE but also have 
may advantages in other subsets of patients. In a recent review of the 
literature, Iacono et al. [20] recommend biliary drainage, limited to 
FLR, in the majority of cases of jaundiced patients who are candidates for 
major liver resection.
FLR and PBD
The importance of having a sufficient liver volume after hepatectomy 
to avoid liver failure is widely known. Hepatic optimization has been 
proposed with this purpose and the drain should be limited to the FLR 
[58]. Hepatectomies for HC are subjected to a higher risk of hepatic 
insufficiency due to the extent of the resection needed and due to the 
presence of preoperative hyperbilirubinemia. Recently, several series of 
hepatic resections for HC confirmed a decreased incidence of hepatic 
insufficiency when PBD was performed together with PVE [59, 60].
A retrospective single center study made in 2005 by Hemming [61] 
reviewed 80 patients affected by HC treated between 1997 and 2004. A 
total of 53 patients were subjected to curative resection, 14 underwent 
palliative surgery while 13 could not be surgically treated due to the 
extent of their disease or co-morbidities. The patients who underwent 
hepatic resection had a postoperative mortality of 9% with a morbidity 
of 40%. Patients having a compensatory FLR hypertrophy (due to PVE 
or tumor’s PV invasion) were found to have a significant lower mortality 
compared to patients without hypertrophy. In the discussion with other 
authors at the end of the article, Hemming underlines that there should 
be some evidences that PBD improves the outcome of patients affected 
by resectable HC. The author suggests that for HC suitable to operation 
there is the risk of having up to 75% of viable liver resected. For this 
reason should be subjected to hepatic optimization prior the operation in 
order to avoid postoperative liver insufficiency. To drain FLR’s bile duct is 
helpful to avoid residual hepatic function. The author concludes that there 
is no doubt that PBD augments bacterial colonization of the bile ducts and 
in some cases the rate of postoperative infections, but clinical implications 
of these findings are uncertain.
Conclusions 
According to our review of the literature, ENBD might offer the 
greatest advantage for the initial management of hyperbilirubinemia in 
HC patients compared to other PBD techniques, because of minimal 
invasiveness, low risk of post procedural complications and virtually 
absent risk of tumour seeding. In case of inadequate decrease in serum 
bilirubin, additional tubes may be placed for optimizing drainage of FLR 
or bilateral liver lobes. However, ENBD demonstrated to be less effective 
and delay jaundice resolution in the event of advanced HC with complete 
or subtotal obstruction of bile ducts and in sub-lobar cholangitis; in these 
conditions, PTBD should be considered as a valid alternative treatment.
Despite the lack of prospective studies and data heterogeneity, we can 
define some principles which are common to many authors (Table 1).
It is a common and accepted opinion that preoperative bile drainage 
is mandatory in presence of obstructive jaundice if associated with renal 
insufficiency, malnutrition, cholangitis and sepsis.
Even if many Asiatic groups use bile drain routinely, PBD was shown 
to be helpful only in those patients having a bilirubin level greater than 
3-10 mg/dl; we might conclude that PBD is probably useless with bilirubin 
level below 3 mg/dl, advisable between 3-10 mg/dl and mandatory above 
10 mg/dl especially in patients undergoing an extended hepatic resection.
In the initial management of HC, ENBD should be preferred as it is 
characterized by a less invasive approach and less complications (lower 
morbidity). In case of suboptimal jaundice regression or in presence of 
complications PTBD might be combined, leaving EBD as last option. The 
number of drainages needed is chosen in relation with jaundice evolution 
and its complications. Drain should be limited to FLR. The optimal drain 
duration is debated: the drain should be left in place the time needed to 
reduce bilirubin level, meanly 2-6 weeks. This is the most variable datum, 
due to the wide spectrum of “normal” bilirubin level reported by the 
different groups.
PBD should be combined with PVE if estimated FLR is less than 
30%. Some data suggest that PBD may be helpful only for those patients 
undergoing right hepatectomy, thus it is not advisable in other cases. 
Further studies are needed in order to confirm these assumptions.
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Type of biliary drainage
Endoscopic Nasobiliary drainage (ENBD) 
as first approach
Percutaneous transhepatic biliary drainage 
(PTBD) as second choice
EBD in selected cases
Preoperative Bilirubin level
Biliary drainage probably useless below 3 
mg/dl 
Biliary drainage advisable between 3-10 
mg/dl
Biliary drainage mandatory above 10 mg/dl
Optimal drain duration 2-6 weeks until optimal bilirubin level achieved
Post-drainage optimal 
bilirubin level < 3 mg/dl
How to drain Only the future liver remnant (except in cases of cholangitis or local complications)
Association with PVE If FLR < 30%
Table 1: Recommendations for preoperative biliary drainage in resectable 
HC
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